Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 129 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1281 9.5 months Recurrent GBM Radiation
Naval Medical Center Portsmouth United States 10/2002
Treatment Details: Patients: This study involved a total of 67 patients, 45 of whom had glioblastoma multiforme. Glioblastoma patients were divided into two groups: 17 patients in Group A who were treated at
 
1282 9.5 months High-grade astrocytoma Radiation
Surgery
Various United Kingdom 1/2001
Treatment Details: Patients: This study involved a total of 674 patients with “high-grade astrocytoma” and included: 449 patients with glioblastoma multiforme, 113 patients with anaplastic astrocytoma, and 112
 
1283 9.5 months Advanced renal cell carcinoma 4 Chemotherapy
San Matteo University Hospital Italy 5/2004
Treatment Details: Patients: This Phase II study involved 42 patients with advanced renal cell carcinoma. All patients had their cancer grow after immunotherapy. There were 31 men and 11 women. The median a
 
1284 9.5 months Unresectable or metastatic renal cell carcinoma 4 Biologic therapy
Chemotherapy
Immunotherapy
Wayne State University School of Medicine United States 8/2001
Treatment Details: Patients: This Phase II study involved 21 patients with unresectable or metastatic renal cell carcinoma;16 men and 5 women. Prior therapies included nephrectomy (13 patients) and immunother
 
1285 9.5 months GBM 4 Chemotherapy
Dana-Farber Cancer Institute United States 4/2007
Treatment Details: Patients: This phase II trial involved twenty-six patients with metastatic melanoma. There were 12 men and 14 women. The median age was 45 years, ranging from 28-70. The patients’ diseas
 
1286 9.5 months Advanced NSCLC 3 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 9/2006
Treatment Details: Patients: This phase I/II trial involved 27 patients with advanced nonsmall cell lung cancer. The median age was 63, ranging from 39-82 years. Ten patients were women, 17 were men, and 5 h
 
1287 9.5 months Advanced NSCLC 5 Chemotherapy
Christie Hospital United Kingdom 7/2006
Treatment Details: Patients: This Phase III trial involved a total of 433 patients with advanced non-small-cell lung cancer. There were 295 men and 138 women. The median age was 63. Patients were divided in
 
1288 9.5 months Stage IIIB/IV NSCLC 4 Chemotherapy
Tohoku University School of Medicine Japan 2/2006
Treatment Details: Patients: This Phase II study involved 120 patients with advanced non-small-cell lung cancer. The patients were randomly divided into two groups. Group B had 60 patients (54 men, 6 women,
 
1289 9.5 months Malignant pleural mesothelioma 5 Chemotherapy
Leeds General Infirmary United Kingdom 5/2008
Treatment Details: Patients: This study involved 409 patients recently diagnosed with malignant pleural mesothelioma. The majority (over 90%) of patients were men. They ranged in age from 46 to 85 years of
 
1290 9.5 months Advanced hepatocellular carcinoma 4 Biologic therapy
Chemotherapy
Hopital Europeen Georges Pompidou France 6/2008
Treatment Details: Patients: This phase II study involved 45 patients with advanced-stage progressive hepatocellular carcinoma. They ranged in age from 22 to 76 years old; the median age was 63 years of age.
 
Page 129 of 187  | Previous Page  | Next Page